Duke Health

This summer, thousands of people across the country have gotten sick after eating food contaminated with a parasite called Cyclospora. Explosive diarrhea is the main symptom of the foodborne illness, known as cyclosporiais. If you get sick, when should you see your healthcare provider? Here, Keley Brennan, Duke Health Nurse Practitioner who sees patients at Duke Health Family Medicine Mooresville and Duke Health Primary Care Tall Oaks, explains what you need to know about cyclosporiasis and how to keep you and your family healthy.

A new generation of image-guided treatments uses radioactive material to target and destroy cancer cells with fewer side effects than standard cancer treatments. Radioligand therapies are approved to treat advanced prostate cancer and neuroendocrine tumors. Clinical trials are underway to expand this therapeutic approach to more cancer types.

Who is a candidate for radioligand therapies, and why are they so effective? In our ongoing Conversations in Cancer series, Diane Reidy-Lagunes, MD, a medical oncologist at Duke Health who specializes in neuroendocrine tumors, talks to Hannah McManus, MD, a medical oncologist who treats prostate cancer, about this “smart bomb” approach and the promises it holds for the future.

Learn more about PLUVICTO and other radioligand therapies.

Two decades after Patrick Schultea underwent treatment for prostate cancer, his prostate-specific antigen (PSA) levels began to rise, signaling that the cancer had returned. Because tiny radioactive seeds had been implanted in his prostate at a local hospital to treat his first bout with cancer, Schultea needed a new approach. He found it at Duke Health. Today, he’s back to renovating his beach house and enjoying life with his family.